Blog

AcuraStem was recently featured in Genetic Engineering & Biotechnology News (GEN) in an article titled "Rewriting Disease: Oligonucleotides Take Aim at the Untreatable." The piece examines rapid advancements in nucleic-acid-based drugs and explores how the biotechnology sector is increasingly turning to antisense oligonucleotides (ASOs) to address severe neurodegenerative conditions.